A61K 9/4858
Organic compounds
Official title: {Organic compounds}
A61K9/4858 (Organic compounds) appears on 2,743 US grants and 4,737 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,743
- Published applications
- 4,737
- Assignees
- 1,760
- Inventors
- 7,806
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 2 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 7 | 0 |
| 1981 | 4 | 0 |
| 1982 | 6 | 0 |
| 1983 | 6 | 0 |
| 1984 | 5 | 0 |
| 1985 | 4 | 0 |
| 1986 | 5 | 0 |
| 1987 | 12 | 0 |
| 1988 | 12 | 0 |
| 1989 | 17 | 0 |
| 1990 | 17 | 0 |
| 1991 | 9 | 0 |
| 1992 | 10 | 0 |
| 1993 | 12 | 0 |
| 1994 | 15 | 0 |
| 1995 | 11 | 0 |
| 1996 | 18 | 0 |
| 1997 | 25 | 0 |
| 1998 | 30 | 0 |
| 1999 | 69 | 0 |
| 2000 | 40 | 0 |
| 2001 | 72 | 20 |
| 2002 | 52 | 71 |
| 2003 | 52 | 138 |
| 2004 | 35 | 118 |
| 2005 | 45 | 113 |
| 2006 | 44 | 97 |
| 2007 | 25 | 99 |
| 2008 | 26 | 103 |
| 2009 | 15 | 110 |
| 2010 | 44 | 118 |
| 2011 | 40 | 118 |
| 2012 | 61 | 143 |
| 2013 | 92 | 189 |
| 2014 | 109 | 252 |
| 2015 | 157 | 268 |
| 2016 | 156 | 254 |
| 2017 | 149 | 287 |
| 2018 | 136 | 248 |
| 2019 | 156 | 265 |
| 2020 | 155 | 288 |
| 2021 | 169 | 293 |
| 2022 | 146 | 231 |
| 2023 | 119 | 242 |
| 2024 | 137 | 293 |
| 2025 | 120 | 229 |
| 2026 | 82 | 150 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- API stability in softgels29 Sep 2026US 12,746,206 B2R.P. Scherer Technologies, LLC
- Pharmaceutical compounds and methods of making and using the same29 Sep 2026US 12,747,208 B2Athos Therapeutics, Inc.
- Cabozantinib compositions and methods of use22 Sep 2026US 12,741,938 B2Handa Oncology, LLC
- Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto15 Sep 2026US 12,734,145 B2Children's Healthcare of Atlanta, Inc.
- Chronic kidney disease treatment or prevention method1 Sep 2026US 12,721,844 B2Shionogi & Co., Ltd.
- Formulations containing tryptamine derivatives and uses thereof8 Oct 2026US 2026/0306453 A1Psilera Inc.
- Hydrogel ink, hydrogel and uses thereof8 Oct 2026US 2026/0306528 A1
- Composition containing cyclic peptide compound and surfactant1 Oct 2026US 2026/0294806 A1Chugai Seiyaku Kabushiki Kaisha
- Cannabidiol formulations1 Oct 2026US 2026/0294812 A1Dsm IP Assets B.V.
- Sleep formulation1 Oct 2026US 2026/0294816 A1NightWise, LLC
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents638US 6,383,471 B1Lipocine Inc. · 2002
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001